Relief Therapeutics Holding AG (OTC: RLFTF) is making a powerful run northbound after NeuroRx reported ZYESAMI™ met the primary endpoint in its Phase 2b/3 trial* for...
RLFTF has been moving northbound in a hurry after its partner NeuroRx, Inc. announced the Phase 2b/3 trial* of ZYESAMI™ (aviptadil, previously RLF-100™) for the treatment of...
Relief Therapeutics Holding SA (SWX: RLF) (OTCQB: RLFTF) is moving steadily higher on accelerating volume showing an increased level of accumulation and buy volume not seen...
Microcapdaily continues to cover the exciting story of Relief Therapeutics Holding SA (SWX: RLF) (OTCQB: RLFTF) that skyrocketed up the charts earlier this year as its...
Relief Therapeutics Holding AG (SWX: RLF) (OTCQB: RLFTF) is making a powerful move up the charts in recent days as heavy buying comes in from Switzerland....
Relief Therapeutics Holding AG (OTCMKTS: RLFTF) is making a powerful move up the charts after a brief dip in recent days. The reversal on RLFTF comes...
